SuperGen, Inc. to Present at A.G. Edwards' Emerging Growth Conference September 18
DUBLIN, Calif., Sept. 12 /PRNewswire-FirstCall/ -- SuperGen Inc. , a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that Gregory Berk, M.D., Chief Medical Officer, is scheduled to present at the A.G. Edwards' Emerging Growth Conference on September 18, 2007, at the New York Palace Hotel.
SuperGen's presentation at the A.G. Edwards' Emerging Growth Conference is scheduled to begin at 3:15 p.m. EDT. A live webcast of the presentation will be available on the investor relations section of the Company's Web site at www.supergen.com. The webcast will be archived for 90 days.
About SuperGen
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.
Contacts Timothy L. Enns Mary M. Vegh SuperGen, Inc. SuperGen, Inc. SVP, Corporate Communications Manager, Investor Relations & Business Development Tel: (925) 560-2845 Tel: (925) 560-0100 E-mail: mary.vegh@supergen.com E-mail: tenns@supergen.com
SuperGen Inc.CONTACT: Timothy L. Enns, SVP, Corporate Communications Manager & BusinessDevelopment, +1-925-560-0100, tenns@supergen.com, or Mary M. Vegh, Manager,Investor Relations, +1-925-560-2845, mary.vegh@supergen.com, both ofSuperGen Inc.
Web site: http://www.supergen.com./